Privacy settings

We use technical cookies, that are necessary for the management of the website, statistical cookies and marketing cookies (including third parties cookies) for displaying individual offers and ads. For more information read our Privacy Policy. Statistical cookies and marketing cookies (inclusive of third parties cookies) are used only with your consent. By clicking “Select all and agree” you consent to our use of statistical and/or marketing cookies (inclusive of third parties cookies).

To customize your privacy settings, tick your preferences in the checkboxes and click “Apply selection”. You can always change the privacy settings and deactivate cookies by following the instructions in the Privacy Policy.

Show preferences Select all and accept
IMA is loading

Injecta's fully isolated robotic technology disrupts the conventional approach to aseptic processing

Current market trends in aseptic fill-finish are now forcing pharmaceutical companies to adopt agile manufacturing strategies and embrace new technologies to meet the actual requirements for a highly variable production process. Central goal is to achieve flexible production in a safe, aseptic environment, implementing cost-saving solutions with a space-efficient design.

Injecta
The queen of perfection

The pharmaceutical industry has been increasingly embracing injectables as a consistently profitable business sector. For decades, injection has been largely limited to in-patient use, with health professionals actively involved in administering doses intravenously, intramuscularly and subcutaneously. The introduction of prefilled syringes and injection devices has reduced the fear factor associated with outpatient injections.